Pet Safety / Compounds / Carisoprodol (Soma)

Is Carisoprodol (Soma) safe for dogs and cats?

Moderate risk for pets

Dogs may ingest carisoprodol through accidental access to owner's prescriptions. Clinical signs in dogs mirror the CNS depressant profile: sedation, ataxia, muscle weakness, and respiratory depression at high doses. Meprobamate accumulation (the active metabolite) prolongs the duration of toxicosis. Treatment is supportive. Carisoprodol is not used in veterinary medicine; exposure is purely from accidental ingestion of human prescriptions.

What is carisoprodol (soma)?

The IUPAC name is [2-(carbamoyloxymethyl)-2-methylpentyl] N-propan-2-ylcarbamate.

Also known as: [2-(carbamoyloxymethyl)-2-methylpentyl] N-propan-2-ylcarbamate, carisoprodol, Isomeprobamate, Carisoprodate.

IUPAC name
[2-(carbamoyloxymethyl)-2-methylpentyl] N-propan-2-ylcarbamate
CAS number
78-44-4
Molecular formula
C12H24N2O4
Molecular weight
260.33 g/mol
SMILES
CCCC(C)(COC(=O)N)COC(=O)NC(C)C
PubChem CID
2576

Risk for dogs

Moderate risk

Dogs may ingest carisoprodol through accidental access to owner's prescriptions. Clinical signs in dogs mirror the CNS depressant profile: sedation, ataxia, muscle weakness, and respiratory depression at high doses. Meprobamate accumulation (the active metabolite) prolongs the duration of toxicosis. Treatment is supportive. Carisoprodol is not used in veterinary medicine; exposure is purely from accidental ingestion of human prescriptions.

Regulatory consensus

2 regulatory and scientific bodies have classified Carisoprodol (Soma). The classifications differ — that's the data.

AgencyYearClassificationNotes
EPA CTX / GenetoxGenotoxicity: negative (Ames: negative, 0 positive / 2 negative reports)
EPA CTX / GenetoxGenotoxicity: negative (Ames: negative, 0 positive / 2 negative reports)

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where pets encounter carisoprodol (soma)

  • Industrial FacilitiesManufacturing plants, Chemical storage areas, Waste treatment sites
  • Occupational EnvironmentsFactories, Warehouses, Transportation vehicles

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Carisoprodol (Soma):

  • Therapeutic alternatives (consult prescriber)
    Trade-offs: Drug-specific. Cannot substitute without medical guidance.
    Relative cost: 1.2-2×

Frequently asked questions

Is carisoprodol (soma) safe for pets?

Dogs may ingest carisoprodol through accidental access to owner's prescriptions. Clinical signs in dogs mirror the CNS depressant profile: sedation, ataxia, muscle weakness, and respiratory depression at high doses. Meprobamate accumulation (the active metabolite) prolongs the duration of toxicosis. Treatment is supportive. Carisoprodol is not used in veterinary medicine; exposure is purely from accidental ingestion of human prescriptions.

What products contain carisoprodol (soma)?

Carisoprodol (Soma) appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).

See Carisoprodol (Soma) in the pets app

Look up products containing carisoprodol (soma), compare to alternatives, and explore the full data record.

Open in pets View raw API data

Sources (2)

  1. US DEA: Carisoprodol (Soma) — Schedule IV Classification (2012), Meprobamate Metabolite Mechanism, 'Soma Coma' Polysubstance Abuse Combination, Withdrawal Seizure Risk, and Prescribing Patterns in Southern US States (2022) (2022) — regulatory
  2. US FDA: Carisoprodol — Prescribing Information, 2–3 Week Maximum Duration, Meprobamate Hepatic Metabolism, Physical Dependence and Withdrawal, Schedule IV Controlled Status, and Pediatric Contraindication (<16 Years) (2022) (2022) — regulatory

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →